The Ducks will ring in December by hosting the Ottawa Senators on Sunday in a matchup of teams that are an eyelash under .500 with designs on gaining some upward momentum. They’ll enter the clash with identical .477 points percentages that situate them near the bottom of their respective divisions but not far behind a crowded pack of middling clubs. The Ducks have had more of a defensive inclination while the Senators have shown more scoring pop to date. Ducks coach Greg Cronin said his team hadn’t “had too many stinkers” of late, and that’s been reflected by their 5-3-1 record across their past nine games, with four of their five-plus-goal games this season arriving in that span. “Since we got back from that New York trip, I think we’ve been on a pretty good path in terms of playing with an identity and competing,” Cronin said. They had to grind hard on Black Friday, when they played what Cronin described as something of a postseason-style game against the Kings at Honda Center. Though they fell 2-1 to what veteran forward Ryan Strome described as a “mature, veteran team” that they couldn’t quite edge past despite playing a “disciplined, structured and north-south” game, the Ducks still felt they carried forward some positive indicators from their recent play. “It was a good hockey game. We competed hard. I thought we dictated a lot of the game. We played similar to the way we’ve been playing,” Strome said. Kings coach Jim Hiller concurred. With teams frequently playing the Southern California franchises back to back, he and Cronin get constant looks at one another’s teams during pre-scouts, and Hiller assessed the Ducks’ performance quite favorably. “I thought – we’ve played them this year, I’ve scouted them this year – I thought that’s the best game they’ve played this year. I thought they played very well,” Hiller said. Time will tell if Sunday’s match elicits similar plaudits from Ottawa coach Travis Green, who spent parts of two seasons with the Ducks as a player and is in his first year as the Sens’ head coach after previously guiding the Vancouver Canucks and New Jersey Devils briefly. Though Brock McGinn has made some progress in his return, he and Robby Fabbri remained unavailable. So, too, did Leo Carlsson, whose upper-body injury has kept him out of the Ducks’ past two matches. Cam Fowler will be a game-time decision. Related Articles Troy Terry has four points across his three-game scoring streak, while Trevor Zegras just snapped a four-gamer that saw him compile six points. For Ottawa, forwards Tim Stützle and Drake Batherson each have seven points in the Sens’ past five outings. Captain Brady Tkachuk, whom Cronin suggested could be a model for his own power forward Mason McTavish, has racked up five points during a three-game surge. Those are the three Senators scoring above a point per game this season, with Stützle’s 28 points in 22 games leading the way. When: 5 p.m. Sunday Where: Honda Center How to watch: Victory+Larson Financial Group LLC Lowers Stake in Vanguard Total International Bond ETF (NASDAQ:BNDX)6 lucky 。

Daiwa Securities Group Inc. lessened its stake in shares of Assurant, Inc. ( NYSE:AIZ – Free Report ) by 3.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,341 shares of the financial services provider’s stock after selling 202 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Assurant were worth $1,261,000 at the end of the most recent quarter. Other hedge funds and other institutional investors also recently modified their holdings of the company. Innealta Capital LLC acquired a new position in shares of Assurant during the second quarter worth about $31,000. Huntington National Bank lifted its stake in shares of Assurant by 509.4% during the third quarter. Huntington National Bank now owns 195 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 163 shares in the last quarter. Richardson Financial Services Inc. lifted its stake in shares of Assurant by 62.1% in the second quarter. Richardson Financial Services Inc. now owns 201 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 77 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in Assurant in the third quarter valued at about $56,000. Finally, Family Firm Inc. acquired a new stake in Assurant during the 2nd quarter valued at approximately $51,000. Institutional investors and hedge funds own 92.65% of the company’s stock. Wall Street Analyst Weigh In AIZ has been the topic of a number of recent analyst reports. Piper Sandler upped their target price on Assurant from $200.00 to $217.00 and gave the company a “neutral” rating in a research report on Wednesday, October 2nd. Truist Financial upped their price target on shares of Assurant from $220.00 to $240.00 and gave the company a “buy” rating in a report on Thursday, November 7th. UBS Group raised their price objective on shares of Assurant from $217.00 to $224.00 and gave the stock a “buy” rating in a report on Monday, September 23rd. StockNews.com downgraded shares of Assurant from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Bank of America boosted their target price on shares of Assurant from $228.00 to $233.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $225.20. Insider Buying and Selling at Assurant In other Assurant news, EVP Biju Nair sold 3,000 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $209.18, for a total transaction of $627,540.00. Following the completion of the transaction, the executive vice president now directly owns 20,658 shares of the company’s stock, valued at $4,321,240.44. The trade was a 12.68 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink . 0.53% of the stock is currently owned by company insiders. Assurant Price Performance Shares of NYSE:AIZ opened at $227.10 on Friday. The company has a quick ratio of 0.42, a current ratio of 0.42 and a debt-to-equity ratio of 0.40. Assurant, Inc. has a fifty-two week low of $160.12 and a fifty-two week high of $230.55. The firm has a 50-day simple moving average of $203.46 and a 200 day simple moving average of $186.07. The company has a market cap of $11.65 billion, a PE ratio of 16.20 and a beta of 0.57. Assurant ( NYSE:AIZ – Get Free Report ) last announced its quarterly earnings data on Tuesday, November 5th. The financial services provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.52 by $0.48. Assurant had a net margin of 6.31% and a return on equity of 17.42%. The business had revenue of $2.97 billion during the quarter, compared to the consensus estimate of $2.94 billion. During the same quarter in the prior year, the firm earned $4.29 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Assurant, Inc. will post 15.41 EPS for the current year. Assurant Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Monday, December 30th. Shareholders of record on Monday, December 9th will be paid a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 1.41%. This is a positive change from Assurant’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Monday, December 9th. Assurant’s payout ratio is presently 22.82%. Assurant Profile ( Free Report ) Assurant, Inc, together with its subsidiaries, provides business services that supports, protects, and connects consumer purchases in North America, Latin America, Europe, and the Asia Pacific. The company operates through two segments: Global Lifestyle and Global Housing. The Global Lifestyle segment offers mobile device solutions, and extended service contracts and related services for consumer electronics and appliances, and credit and other insurance products; and vehicle protection, commercial equipment, and other related services. Read More Want to see what other hedge funds are holding AIZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Assurant, Inc. ( NYSE:AIZ – Free Report ). Receive News & Ratings for Assurant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assurant and related companies with MarketBeat.com's FREE daily email newsletter .

Tasmania’s $1 billion salmon industry will supply thousands of Australian households this Christmas, its fresh and smoked fish fillets a relatively cheap alternative to many seafood options. But what is the environmental cost? Salmon farming in Tasmania. Credit: Adam Gibson Tasmania’s big three salmon producers – foreign-owned companies Huon, Tassal and Petuna – promote the industry as sustainable, with low environmental impacts. But the industry’s critics warn it is poorly regulated, environmentally harmful and expanding at an unsustainable pace. Seafood shoppers face a difficult task in deciding who to trust, especially with political leaders gearing up for an election stoush over the future of the industry. Fishy issues Salmon farms have been blamed for environmental degradation around the Tasmanian coastline, antibiotics leaking into the food chain, algal blooms, dead seals and introduction of hundreds of thousands of escapee fish into the environment. However, Salmon Tasmania chief executive Luke Martin, who heads the peak body for the industry, said the farms were a good fit for the Tasmanian environment. “We know millions of Australians will have salmon on the menu this Christmas lunch, and by doing so, they are supporting the livelihoods of 5000 Australians living across regional Tasmanian communities,” Martin said. “Salmon is also a responsibly sourced seafood farmed under the highest environmental regulatory conditions of any farmed protein in Australia. “Aquaculture also eases demand pressure on our wild fishing stocks.” A salmon farm in Tasmania. Credit: Getty Images/iStockphoto Salmon Tasmania’s website states the regulations strike a balance between growing a vital protein source, which is produced with minimal environmental impacts due to careful management. The industry states its physical footprint on the water is 4000 hectares, compared to 426 million for agriculture on land. “Tasmanian waterways are not, and never can be, overrun by salmon pens,” it said. Green gripes However, environmental groups paint a different picture. Loading “The industry puts into the sea more pollutants than all of Tasmania’s sewage outfalls combined,” said Australian Marine Conservation Society sustainable seafood program manager Adrian Meder. The organisation’s GoodFish sustainable seafood guide told shoppers to reject Tasmanian farmed salmon this Christmas, warning that the huge expansion of the industry’s footprint “could lead to high environmental impacts”. Wild fish kilometres from salmon farms have been found with antibiotic residue in their flesh. There are strict health guidelines around food containing antibiotics, due to the potential for uncontrolled use to lead to the creation of so-called superbugs in the human population. Farmed salmon are sometimes treated with antibiotics to prevent infections that can kill fish or hurt production levels. The Salmon Tasmania website said only its veterinarians can prescribe antibiotics. Meder said nutrient-rich salmon waste is churned out from salmon pens, disrupting the marine ecosystem. It has been linked to algal blooms that have, in some instances, clogged inshore reefs in several locations near farms. A Tasmanian parliamentary inquiry completed in 2022 warned that the industry’s rapid growth had been facilitated by the state government, which is “an enthusiastic promoter and supporter of the industry”. It included several scientific expert submissions that warned about algal outbreaks and issued a recommendation for “ceasing operations in sensitive, sheltered and biodiverse areas” – a call Meder said had been ignored. Salmon Tasmania rejected these claims. Loading “We do not know who the Australian Marine Conservation Society is, what their agenda is, or who funds them, but we are very confident in the sustainability of our operations across Tasmania,” Martin said. Harbouring doubts Macquarie Harbour on Tasmania’s west coast is not the main source of salmon supply, producing around 13 per cent of annual production. But it is where the most controversial leases are, because it is the only home for the incredibly rare and ancient relic, the Maugean skate, of which there are only 40 to 120 adults left in the wild. Salmon farming began there in the late 1980s, and all three of Tasmania’s salmon companies, Tassal, Huon and Petuna, operate in the waterway. They have recently scaled back the size of their operations as concerns about the industry’s impact on the critically endangered fish grew. The federal government’s threatened species committee said in August the best way to save the endangered fish was to eliminate, or at least dramatically cut back on, salmon farming in its habitat. The committee said there was a “significant correlation” between low oxygen levels and an increase in salmon farming. Farmed fish suck up a lot of the oxygen in the water, while fish food and faeces that enter the water via the salmon pens feed oxygen-consuming bacteria. Salmon farmers are trialling mechanical systems that push micro bubbles of oxygen to the bottom of the harbour. “No fish farming should ever pose an extinction threat to an endangered species, and no other fish farming industry in Australia does,” Meder said. “It’s actually really easy to do fish farming better than this.” Salmon Tasmania has warned that scaling back the industry could cut the 260 local jobs that it generates and claimed that multiple factors affected water quality, not just farming, including climate change and disruption from hydroelectric dams to river flows into Macquarie Harbour. Political fallout Federal Environment Minister Tanya Plibersek has on her desk a request from environment groups to revoke licences for farming in Macquarie Harbour, but a decision is not expected before an election due by May. Opposition Leader Peter Dutton has accused the government of seeking to shut down the salmon industry. “The government’s prepared to hang the local community out to dry,” he said this month. Macquarie Harbour is in the Braddon electorate, which the Liberal Party won from Labor at the 2019 election. Prime Minister Anthony Albanese has hopes to win Braddon back. He visited on December 14 and declared he would not pre-empt Plibersek’s legal responsibilities as environment minister, but nevertheless guaranteed the industry would continue under his leadership. Prime Minister Anthony Albanese visits salmon farms in Macquarie Harbour, on Tasmania’s west coast. “As long as I’m prime minister, there will be support for jobs here in Tasmania because I understand how important it is for the Tasmanian economy,” Albanese declared. Plibersek was absent from his visit. However, Plibersek said on December 19 that she welcomed the prime minister’s presence in Tasmania and echoed his support for the industry. But it was far harder to interpret her position on the future of the industry, which she said must be weighed against environmental concerns. “We know that the salmon industry is important for local jobs in Tasmania, but we also know that Tasmanians really value their natural environment ... I’m not going to comment on any decision that is before me at the moment.” Cut through the noise of federal politics with news, views and expert analysis. Subscribers can sign up to our weekly Inside Politics newsletter . Save Log in , register or subscribe to save articles for later. License this article Farming Salmon Environmental protection Seafood Animals Mike Foley is the climate and energy correspondent for The Age and The Sydney Morning Herald. Connect via email . Most Viewed in Politics LoadingDublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Burkitt Lymphoma - Global Clinical Trials Review, 2024" has been added to ResearchAndMarkets.com's offering. The clinical trial report provides an overview of Burkitt Lymphoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Burkitt Lymphoma. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. The clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Report Scope The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months Reasons to Buy Assists in formulating key business strategies with regards to investment Helps in identifying prominent locations for conducting clinical trials which saves time and cost Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities Supports understanding of trials count and enrollment trends by country in global therapeutics market Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial assessment of the indication on a global, regional and country level Key Topics Covered: Clinical Trials Report Coverage Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing to Clinical Trials in Asia-Pacific Top Five Countries Contributing to Clinical Trials in Europe Top Countries Contributing to Clinical Trials in North America Top Five Countries Contributing to Clinical Trials in Middle East and Africa Top Countries Contributing to Clinical Trials in Central and South America Clinical Trials by G7 Countries: Proportion of Burkitt Lymphoma to Oncology Clinical Trials Clinical Trials by Phase in G7 Countries Clinical Trials in G7 Countries by Trial Status Clinical Trials by E7 Countries: Proportion of Burkitt Lymphoma to Oncology Clinical Trials Clinical Trials by Phase in E7 Countries Clinical Trials in E7 Countries by Trial Status Clinical Trials by Phase In Progress Trials by Phase Clinical Trials by Trial Status Clinical Trials by End Point Status Subjects Recruited Over a Period of Time Clinical Trials by Sponsor Type Prominent Sponsors Top Companies Participating in Burkitt Lymphoma Therapeutics Clinical Trials Prominent Drugs Clinical Trial Profile Snapshots Abbreviations Company Coverage: Bristol-Myers Squibb Co Pfizer Inc Takeda Pharmaceutical Co Ltd Roche Holding AG Amgen Inc Gilead Sciences Inc Merck & Co Inc Novartis AG Sanofi Sian Wuhan Medical Technology Co Ltd For more information about this clinical trials report visit https://www.researchandmarkets.com/r/c5m5c6 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.U.S. owner Textor helps Botafogo to historic South American title - ESPN

All you need to know about the new MyWay+ ticketing systemPierpont aviation facility project at NCWV Airport still on track, officials say

None

No. 22 Illinois reaches 9 wins for first time in 17 years with 38-28 victory over NorthwesternWhen choosing an eye cream, consider your specific concerns—such as hydration, anti-aging, puffiness, or dark circles. SK-II offers deep hydration, Jurlique targets fine lines, CeraVe is perfect for sensitive skin, and Laneige addresses puffiness and firmness. Select the best eye cream based on your skin's unique needs. People frequently notice the eyes first, and the sensitive skin surrounding them is among the first places to exhibit indications of stress, ageing, and exhaustion. The eye area needs specific treatment for everything from fine lines and wrinkles to puffiness and dark circles. This article will shed light on the world of eye creams and provide you the information you need to select the best product for hydrating, brightening, and revitalising your eyes. 1. SK-II SKINPOWER Eye Cream 2.5g Image Source- Zalora.com.my Order Now The SK-II SKINPOWER Eye Cream is an anti-aging eye cream designed to hydrate and improve the skin's resilience against daily stressors. It features SK-II's signature ingredient, PITERATM, along with InfinitPower Technology. Key Features: 2. Jurlique Herbal Recovery Signature Eye Cream (15ml/0.5oz) Image Source- Zalora.com.my Order Now Jurlique's Herbal Recovery Signature Eye Cream is a deeply nourishing, anti-aging treatment designed specifically for the delicate skin around the eyes. This luxurious cream is formulated with a blend of powerful botanicals and natural-based antioxidants. Key Features: 3. CeraVe Eye Repair Cream (14ml) Image Source- Zalora.com.my Order Now The CeraVe Eye Repair Cream is a hydrating eye cream designed to address common concerns like dark circles and puffiness. Key Features: 4. Laneige Bouncy & Firm Eye Sleeping Mask - 20g - Depuff, Firm & Blur Fine Lines Image Source- Zalora.com.my Order Now Laneige's Bouncy & Firm Eye Sleeping Mask is a refreshing, overnight treatment designed to target puffiness, firm the under-eye area, and reduce the appearance of fine lines. This innovative eye mask features a unique Cooling Cloud Texture. Key Features: In conclusion, the type of eye cream you choose will depend on your particular problems, such as dark circles, puffiness, anti-aging, or hydration. A rich, botanical approach to nourishing and revitalising the skin is provided by Jurlique's Herbal Recovery Signature Eye Cream, while SK-II's SKINPOWER Eye Cream is perfect for individuals looking for deep hydration and anti-aging benefits. For sensitive skin, CeraVe's Eye Repair Cream offers a mild, calming solution that hydrates for a long time. For people who want to address puffiness and increase skin elasticity, Laneige's Bouncy & Firm Eye Sleeping Mask is a fantastic overnight remedy. Because every product has different substances and advantages, choosing the best one will rely on your preferences and the demands of your skin. Disclaimer: The above mentioned article is a sponsored feature. This article is a paid publication and does not have journalistic/editorial involvement of IDPL, and IDPL claims no responsibility whatsoever. Stay informed on all the latest news , real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.

News24 | Why South Africa could lead emerging markets under TrumpSolar panels contain twice as much silver today than they did five years ago, highlighting how important the precious metal is in just one technology needed for the green energy transition. Yet its usage today in the panels comes after manufacturers tried to cut silver content to reduce costs, frustrating customers with lower panel efficiency, according to First Majestic Silver (TSX: AG; NYSE: AG) CEO Keith Neumeyer. “Copper’s the highway, silver’s the glue” Neumeyer told The Northern Miner’s International Metals Symposium in London on Dec. 2. Silver is indispensable alongside other critical minerals in energy transition technologies like the rods inside nuclear plants, he said. They’re made with 80% silver. Despite its green energy role, silver production faces permitting headwinds that slow its ability to meet demand, Pan American Silver (TSX: PAAS; NYSE: PAAS) CEO and president Michael Steinmann, said on the panel with Neumeyer. The Northern Miner podcast host Adrian Pocobelli moderated the discussion. Silver production has “flatlined” over the last 10 years, during which it has fluctuated between 830 million and 850 million oz. per year, Steinmann said. Meanwhile, silver prices, currently at $29.51 per oz., would need to touch US$100 per oz. for a decade to change the supply fundamentals of the market, Neumeyer said. Watch the full discussion below: https://vimeo.com/manage/videos/1041179651

Banque Cantonale Vaudoise Sells 50 Shares of ASML Holding (NASDAQ:ASML)TDP calls for Waqf Bill to protect Muslim interests ahead of parliament session

Dodgers announce 5-year contract with LHP Blake Snell‘I think the conditions saved them today’: Steelers’ reaction to 24-19 upset loss to the Browns

The annual rivalry matchup between the Florida Gators and Florida State Seminoles occurs on Saturday. Florida State has won the last two meetings of the in-state foes, but Florida leads the all-time series 37-28-2. Florida and Florida State have had two different seasons in 2024. Gators head coach Billy Napier was on the hot seat entering the season after six wins in 2022 and five wins in 2023. It has been a disastrous campaign for Florida State after what happened last season. The Seminoles were undefeated after winning the 2023 ACC championship over the Louisville Cardinals. However, quarterback Jordan Travis suffered a season-ending injury in the North Alabama game, and Florida State missed the College Football Playoff. The Seminoles went to the Orange Bowl and lost to the Georgia Bulldogs 63-3. Florida State just picked up its second win of the season on Saturday after beating Charleston Southern. The Seminoles scored over 21 points for the first time in 12 games. Florida Athletic Director Scott Stricklin confirmed that Billy Napier will be in Gainesville next season. The Gators are fresh off a 24-17 upset of the No. 9 Ole Miss Rebels and clinched a bowl game appearance with the win. Doug Engle/Gainesville Sun / USA TODAY NETWORK Florida State won last year's meeting, but FanDuel favors Florida this time. The Gators enter the matchup as a 14.5-point favorite. The game will be in Tallahassee this season and kicks off Saturday at 7 p.m. ET on ESPN2. Related: Paul Finebaum Explains Irony of Florida’s Upset Of Ole Miss

Jennison Associates LLC purchased a new position in Cushman & Wakefield plc ( NYSE:CWK – Free Report ) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 54,699 shares of the company’s stock, valued at approximately $746,000. A number of other institutional investors have also added to or reduced their stakes in CWK. Blue Trust Inc. grew its position in shares of Cushman & Wakefield by 137.5% in the 3rd quarter. Blue Trust Inc. now owns 3,501 shares of the company’s stock worth $48,000 after buying an additional 2,027 shares during the period. CWM LLC grew its holdings in Cushman & Wakefield by 61.4% in the second quarter. CWM LLC now owns 5,468 shares of the company’s stock worth $57,000 after purchasing an additional 2,080 shares during the period. GAMMA Investing LLC grew its holdings in Cushman & Wakefield by 45.8% in the third quarter. GAMMA Investing LLC now owns 5,186 shares of the company’s stock worth $71,000 after purchasing an additional 1,629 shares during the period. Profund Advisors LLC bought a new position in shares of Cushman & Wakefield during the second quarter valued at approximately $105,000. Finally, KBC Group NV lifted its holdings in shares of Cushman & Wakefield by 31.7% during the third quarter. KBC Group NV now owns 7,961 shares of the company’s stock valued at $109,000 after purchasing an additional 1,915 shares during the last quarter. Institutional investors own 95.56% of the company’s stock. Cushman & Wakefield Stock Performance Shares of CWK stock opened at $14.44 on Friday. The company has a market capitalization of $3.31 billion, a price-to-earnings ratio of 39.03 and a beta of 1.30. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.18 and a current ratio of 1.18. Cushman & Wakefield plc has a one year low of $8.09 and a one year high of $16.11. The company’s 50-day moving average is $13.54 and its 200 day moving average is $12.32. Wall Street Analysts Forecast Growth Separately, JPMorgan Chase & Co. upped their price target on Cushman & Wakefield from $12.00 to $14.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 30th. Read Our Latest Stock Report on Cushman & Wakefield Cushman & Wakefield Company Profile ( Free Report ) Cushman & Wakefield plc, together with its subsidiaries, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom, and internationally. The company operates through Americas; Europe, Middle East and Africa; and Asia Pacific segments. Featured Stories Want to see what other hedge funds are holding CWK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cushman & Wakefield plc ( NYSE:CWK – Free Report ). Receive News & Ratings for Cushman & Wakefield Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cushman & Wakefield and related companies with MarketBeat.com's FREE daily email newsletter .